Focal radiation necrosis of the brain in patients with melanoma brain metastases treated with pembrolizumab.

Melanoma patients with MBM treated with radiosurgery and showing a beneficial response to pembrolizumab are at risk for late RNB. In case of suspected isolated progression at the site of a previously irradiated MBM, the diagnosis of RNB should be considered.